U.S. Markets closed
  • S&P 500

    4,163.26
    -22.21 (-0.53%)
     
  • Dow 30

    34,077.63
    -123.04 (-0.36%)
     
  • Nasdaq

    13,914.77
    -137.58 (-0.98%)
     
  • Russell 2000

    2,232.00
    -30.67 (-1.36%)
     
  • Crude Oil

    63.54
    +0.16 (+0.25%)
     
  • Gold

    1,771.20
    +0.60 (+0.03%)
     
  • Silver

    25.86
    +0.03 (+0.11%)
     
  • EUR/USD

    1.2044
    +0.0003 (+0.0241%)
     
  • 10-Yr Bond

    1.6010
    +0.0280 (+1.78%)
     
  • Vix

    17.29
    +1.04 (+6.40%)
     
  • GBP/USD

    1.3985
    +0.0001 (+0.0084%)
     
  • USD/JPY

    108.1400
    -0.0100 (-0.0092%)
     
  • BTC-USD

    55,889.30
    -374.73 (-0.67%)
     
  • CMC Crypto 200

    1,273.66
    -25.30 (-1.95%)
     
  • FTSE 100

    7,000.08
    -19.45 (-0.28%)
     
  • Nikkei 225

    29,685.37
    +2.00 (+0.01%)
     

GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference

  • Oops!
    Something went wrong.
    Please try again later.
GenMark Diagnostics, Inc.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen 41st Annual Health Care Conference.

GenMark’s management team is scheduled to present in a virtual setting on Monday, March 1st, 2021 at 2:00 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com

ABOUT GENMARK
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark’s eSensor XT-8® and ePlex® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit genmarkdx.com

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com